Related Experiment Video
Updated: Jan 28, 2026

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
Overcoming BET Inhibitor Resistance in Malignant Peripheral Nerve Sheath Tumors
Jonathan M Cooper1, Amish J Patel1,2, Zhiguo Chen1
1Department of Dermatology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas.
Purpose:
BET bromodomain inhibitors have emerged as a promising therapy for numerous cancer types in preclinical studies, including neurofibromatosis type 1 (NF1)-associated malignant peripheral nerve sheath tumor (MPNST). However, potential mechanisms underlying resistance to these inhibitors in different cancers are not completely understood. In this study, we explore new strategy to overcome BET inhibitor resistance in MPNST.Experimental Design: Through modeling tumor evolution by studying genetic changes underlying the development of MPNST, a lethal sarcoma with no effective medical treatment, we identified a targetable addiction to BET bromodomain family member BRD4 in MPNST. This served as a controlled model system to delineate mechanisms of sensitivity and resistance to BET bromodomain inhibitors in this disease.
Results:
Here, we show that a malignant progression-associated increase in BRD4 protein levels corresponds to partial sensitivity to BET inhibition in MPNST. Strikingly, genetic depletion of BRD4 protein levels synergistically sensitized MPNST cells to diverse BET inhibitors in culture and in vivo.
Conclusions:
Collectively, MPNST sensitivity to combination genetic and pharmacologic inhibition of BRD4 revealed the presence of a unique addiction to BRD4 in MPNST. Our discovery that a synthetic lethality exists between BET inhibition and reduced BRD4 protein levels nominates MPNST for the investigation of emerging therapeutic interventions such as proteolysis-targeting chimeras (PROTACs) that simultaneously target bromodomain activity and BET protein abundance.
Insights
Neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors (MPNST) show addiction to BRD4. Reducing BRD4 levels synergistically enhances sensitivity to BET inhibitors, offering a new therapeutic strategy for MPNST.
Area of Science:
- Oncology
- Cancer Biology
- Pharmacology
Background:
- BET bromodomain inhibitors show promise for various cancers, including NF1-associated MPNST.
- Mechanisms of resistance to BET inhibitors are not fully understood.
- MPNST is a lethal sarcoma lacking effective medical treatments.
Purpose of the Study:
- To explore strategies for overcoming BET inhibitor resistance in MPNST.
- To identify targetable dependencies in MPNST development and progression.
- To delineate mechanisms of sensitivity and resistance to BET inhibitors in MPNST.
Main Methods:
- Modeling tumor evolution and genetic changes in MPNST.
- Investigating the role of BRD4 in MPNST sensitivity and resistance.
- Utilizing genetic depletion and pharmacologic inhibition of BRD4.
- Evaluating BET inhibitor efficacy in vitro and in vivo.
Main Results:
- MPNST exhibits a malignant progression-associated increase in BRD4 protein levels.
- Genetic depletion of BRD4 synergistically sensitizes MPNST cells to BET inhibitors.
- This sensitization was observed both in cell culture and in vivo.
Conclusions:
- MPNST demonstrates a unique addiction to BRD4.
- A synthetic lethality exists between BET inhibition and reduced BRD4 protein levels.
- This finding supports the investigation of therapeutics like PROTACs for MPNST.
More Related Videos
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
Related Concept Videos
Peripheral Nervous System: Ganglia and Nerves
Nerves
The nerve is a bundle of axons that serves as the communication highway in the PNS. Each nerve is ensheathed in a protective layer of connective tissue called the epineurium. This outermost layer safeguards the nerve and supports the...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Resistivity
Resistance
Equivalent Resistance